Correlation Between Blueprint Medicines and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Blueprint Medicines and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Reviva Pharmaceuticals.
Diversification Opportunities for Blueprint Medicines and Reviva Pharmaceuticals
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Reviva is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Reviva Pharmaceuticals
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.47 times more return on investment than Reviva Pharmaceuticals. However, Blueprint Medicines Corp is 2.11 times less risky than Reviva Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about -0.01 per unit of risk. If you would invest 4,429 in Blueprint Medicines Corp on September 1, 2024 and sell it today you would earn a total of 5,209 from holding Blueprint Medicines Corp or generate 117.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Reviva Pharmaceuticals |
Blueprint Medicines and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Reviva Pharmaceuticals
The main advantage of trading using opposite Blueprint Medicines and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Reviva Pharmaceuticals vs. Tff Pharmaceuticals | Reviva Pharmaceuticals vs. Eliem Therapeutics | Reviva Pharmaceuticals vs. Inhibrx | Reviva Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |